|
| Toxicities | |||||
| Hematological | Renal | Digestive | Neurological | Mucosa | Skin | |
| TAX-Platine (n = 21) | 8 (38%) | 0 | 7 (33%) | 2 (9%) | 0 | 0 |
| NAV-Platine (n = 11) | 4 (36%) | 2 (18%) | 4 (36%) | 1 (9%) | 0 | 0 |
| 5FU-Platine (n = 23) | 9 (39%) | 3 (13%) | 3 (13%) | 0 | 8 (34%) | 0 |
| Erlotinib (n = 2) | 0 | 0 | 0 | 0 | 0 | 2 (100%) |
| TAX-Beva (n = 1) | 1 (100%) | 0 | 0 | 0 | 0 | 0 |